are there any oral glp-1 drugs GLP-1s rapidly expanding user base List of approved and pending

Increasingly, reports suggest a possible association between GLP-1 RA use and enhanced fertility outcomes, particularly in women with obesity or polycystic ovary syndrome (PCOS)

That created 4 groups based on the medical treatment of T2DM) including GLP-1 agonists (N= 232,210), sulfonylureas (N= 247,146), Dipeptidyl peptidase-4 (DPP-4i) inhibitors (N= 225,116), and SGLT2i inhibitors (sodium-glucose cotransporter 2 inhibitors) (N= 429,172)

Moving from peptide-based biologics to small molecules like orforglipron redefines scalability, simplifies supply chains, and expands global reach

Generative AI statement The author(s) declared that generative AI was used in the creation of this manuscript

Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K/AKT/NF-B signaling in the granulosa cells of PCOS patients

A medicinal chemistry focused analysis